Cardiologs is committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud technology
Cardiologs Unveils New Solution. (Credit: fancycrave1 from Pixabay.)
Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the launch of Cardiologs RPM – an innovative new solution that unlocks the potential of smartwatches for remote cardiac patient monitoring. Cardiologs will debut the new offering at the Heart Rhythm Society’s annual meeting, Heart Rhythm 2021 (Booth #845), which takes place July 28 – 31, 2021 in Boston, Mass.
The Cardiologs RPM platform is the company’s first venture into the remote patient monitoring space, bringing its foundational ECG analysis tool to a more direct level of patient care with the goal of going beyond the world of arrhythmias.
A growing number of smartwatches are now capable of capturing an ECG, and older adults are increasingly using them to monitor a variety of aspects about their personal health. Devices such as the Apple Watch are approved by the FDA as cardiac monitors that can be used to detect atrial fibrillation (AFib) and to better understand patients’ symptoms. In a recent study involving Cardiologs AI, ECG data collected with Smartwatches was also used to monitor QT-prolongation, a life-threatening heart rhythm disorder that is associated with more than 300 commonly-used drugs.
“It is an exciting trend to see patients embracing this technology, which has the potential to transform the traditional care pathway by enabling a much closer following of their condition. However, this places a burden on physicians like we have never seen before and it’s great to see that Cardiologs is entering this space to address this problem,” said Dr. Jagmeet Singh, a cardiologist at Massachusetts General Hospital (MGH) and Professor of Medicine at Harvard Medical School.
While smartwatch users can easily take an ECG whenever they want, sharing and handling that information remains a challenge. Today, most patients have to manually send their ECG recordings in PDF format via email to their clinicians. The frequency with which patients can record and share results creates a fast-growing and overwhelming amount of data that is decentralized, untriaged and non-billable to analyze. The lack of data integration into the clinical workflow is a key reason why few cardiac professionals are ready to embrace smartwatch capabilities.
“The unstructured and decentralized flow of clinical information is limiting smartwatches from making their way into clinical practice at scale. Our platform will address these challenges by automating and streamlining the data-sharing and data-reviewing process,” said Yann Fleureau, Cardiologs’ Co-Founder and CEO. “The Cardiologs RPM Platform will prioritize the data and information that needs the most attention, provide physicians with an efficient workflow to review ECG strips, and implement a billing mechanism to monetize time spent on analysis.”
The Cardiologs RPM platform includes:
A patient mobile app for secure, seamless and automatic ECG data transfer and patient engagement optimization
A physician cloud-based platform to centralize and triage data according to their clinical relevance, as well as streamline ECG review
The platform will enable precision medicine in cardiac practices – empowering doctors to know what types of treatment are successful, which treatment plans need to be escalated, or when dosing needs to be adjusted. Physicians will now be able to leverage cardiac data in real time to pinpoint the right treatments for each individual patient – revolutionizing cardiac care.
Source: Company Press Release